Kenichi Nishiyama
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Gastric-Type Adenomas of the Nonampullary Duodenum: Reappraisal of Clinicopathological and Molecular Features and a Proposal for Novel Classification.
Journal: The American journal of surgical pathology
Published: March 19, 2026
A Case of Hormone Receptor-Positive, HER2-Negative Metastatic Recurrent Breast Cancer Successfully Treated with Capivasertib and Fulvestrant in Late-Line Therapy
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 17, 2026
C4orf3 Regulates HIF-1α Degradation Under Hypoxic Conditions and Contributes to the Malignant Phenotype in Small Cell Lung Cancer.
Journal: Journal of Cancer
Published: November 05, 2025
Primary cardiac angiosarcoma with right atrial rupture.
Journal: Interdisciplinary cardiovascular and thoracic surgery
Published: April 01, 2025
Intraventricular Pilocytic Astrocytoma in a 75-Year-Old Adult Patient: A Case Report.
Journal: Cureus
Published: February 24, 2025
Genetic profiles and clinical features in subcutaneous panniculitis-like T-cell lymphomas.
Journal: Cancer science
Published: April 30, 2024
Renal Failure Without Hemodialysis Is a Risk Factor for Postoperative Complications in Colorectal Cancer Surgery.
Journal: Cancer diagnosis & prognosis
Published: January 09, 2024
Comparative analyses of tumour immune microenvironment between collecting duct carcinoma and fumarate hydratase-deficient renal cell carcinoma.
Journal: Journal of clinical pathology
Published: September 14, 2022
Hysterectomy through Minimally Invasive Surgery for Cervical High-grade Intraepithelial Neoplasia: Reassessment of the Specimens' Eligibility for Histological Examination.
Journal: Gynecology and minimally invasive therapy
Published: June 07, 2022
Approach for reclassification of collecting duct carcinoma and comparative histopathological analysis with SMARCB1/INI1-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinoma.
Journal: Human pathology
Published: February 08, 2022
Corrigendum to "PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor" [Volume 14, Issue 9, September 2021, 101152].
Journal: Translational oncology
Published: January 18, 2022
PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor.
Journal: Translational oncology
Published: April 29, 2021
Last Updated: 09/26/2026